PMID- 19493691
OWN - NLM
STAT- MEDLINE
DCOM- 20090821
LR  - 20191210
IS  - 1769-6658 (Electronic)
IS  - 1278-3218 (Linking)
VI  - 13
IP  - 4
DP  - 2009 Jul
TI  - [Impact of FDG-PET on radiation therapy: economic results of a STIC study].
PG  - 313-7
LID - 10.1016/j.canrad.2009.03.002 [doi]
AB  - The aim of this study is to assess the effects of Positron Emission Tomography 
      (PET) associated with computed tomography (CT) on resource allocation (costs and 
      savings) of the following treatment in radiotherapy for non small cell lung 
      cancers (NSCLC) and Hodgkin's diseases. A national prospective study was 
      conducted in nine hospitals. Two treatment decisions made on the basis of CT only 
      or on PET associated with, were compared in a before-after design. The direct 
      medical cost of using PET was assessed by micro-costing. The costs of new exams 
      and the costs and savings associated with changes in the chosen treatment were 
      calculated on the basis of reimbursement rates. The economic study was conducted 
      over 2 years and included 209 patients (97 patients with Hodgkin's disease and 
      112 with NSCLC). The mean cost of using PET, corresponding to an extra cost, was 
      approximately 800 euro (50% for the radionuclide FDG). Radiotherapy treatments 
      were modified for only 10% of patients with Hodgkin's disease with a minor impact 
      on treatment costs versus 40% of patients with lung cancer with a reduction in 
      mean treatment cost of more than 500 euro.
FAU - Remonnay, R
AU  - Remonnay R
AD  - Universite de Lyon, and Centre Leon-Berard, 28 rue Laennec, Lyon, France. 
      remonnay@lyon.fnclcc.fr
FAU - Morelle, M
AU  - Morelle M
FAU - Giammarile, F
AU  - Giammarile F
FAU - Pommier, P
AU  - Pommier P
FAU - Carrere, M-O
AU  - Carrere MO
LA  - fre
PT  - Evaluation Study
PT  - Journal Article
PT  - Multicenter Study
PT  - Research Support, Non-U.S. Gov't
TT  - L'apport de la tomographie par emission de positons au FDG pour la radiotherapie: 
      resultats de l'evaluation economique du Stic "TEP et radiotherapie".
DEP - 20090602
PL  - France
TA  - Cancer Radiother
JT  - Cancer radiotherapie : journal de la Societe francaise de radiotherapie 
      oncologique
JID - 9711272
RN  - 0 (Radiopharmaceuticals)
RN  - 0Z5B2CJX4D (Fluorodeoxyglucose F18)
SB  - IM
MH  - Carcinoma, Non-Small-Cell Lung/*diagnostic imaging/economics/radiotherapy
MH  - Fluorodeoxyglucose F18/*economics
MH  - France
MH  - Hodgkin Disease/*diagnostic imaging/economics/radiotherapy
MH  - Humans
MH  - Lung Neoplasms/*diagnostic imaging/economics/radiotherapy
MH  - Positron-Emission Tomography/*economics/methods
MH  - Prospective Studies
MH  - Radiopharmaceuticals/*economics
MH  - Tomography, X-Ray Computed/economics/methods
EDAT- 2009/06/06 09:00
MHDA- 2009/08/22 09:00
CRDT- 2009/06/05 09:00
PHST- 2008/11/18 00:00 [received]
PHST- 2009/02/04 00:00 [revised]
PHST- 2009/03/08 00:00 [accepted]
PHST- 2009/06/05 09:00 [entrez]
PHST- 2009/06/06 09:00 [pubmed]
PHST- 2009/08/22 09:00 [medline]
AID - S1278-3218(09)00047-X [pii]
AID - 10.1016/j.canrad.2009.03.002 [doi]
PST - ppublish
SO  - Cancer Radiother. 2009 Jul;13(4):313-7. doi: 10.1016/j.canrad.2009.03.002. Epub 
      2009 Jun 2.